Stay updated with breaking news from Day Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Epigenomics AG / Key word(s): Corporate Action/MiscellaneousEpigenomics AG: Capital reduction planned at a ratio of 5 : 1 02-Aug-2023 / 10:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely...
EQS-Ad-hoc: Epigenomics AG / Key word: Corporate Action/Miscellaneous Epigenomics AG: Capital reduction planned at a ratio of 5 : 1 02-Aug-2023 / 10:36 CET/CEST Disclosure of...
EQSAdhoc Epigenomics AG Key word Corporate ActionMiscellaneous Epigenomics AG Capital reduction planned at a ratio of 5 1 02Aug2023 1036 CETCEST Disclosure of an inside information acc to Article 17
EQS-News: Epigenomics AG / Key word: Strategic Company Decision/Contract Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets ...
EQS-Ad-hoc: Epigenomics AG / Key word: Strategic Company Decision/Contract Epigenomics AG: Agreement on the Acquisition of Almost All Assets 24-Jul-2023 / 18:29...